Isoalantolactone inhibits constitutive NF-κB activation and induces reactive oxygen species-mediated apoptosis in osteosarcoma U2OS cells through mitochondrial dysfunction

Di,Weihua; Khan,Muhammad; Rasul,Azhar; Sun,Meiyan; Sui,Yujie; Zhong,Lili; Yang,Longfei; Zhu,Qi; Feng,Liangtao; Ma,Tonghui

doi:10.3892/or.2014.3368

Isoalantolactone inhibits constitutive NF-κB activation and induces reactive oxygen species-mediated apoptosis in osteosarcoma U2OS cells through mitochondrial dysfunction

Authors:
- Weihua Di
- Muhammad Khan
- Azhar Rasul
- Meiyan Sun
- Yujie Sui
- Lili Zhong
- Longfei Yang
- Qi Zhu
- Liangtao Feng
- Tonghui Ma
View Affiliations

Affiliations: Central Research Laboratory, Jilin University Bethune Second Hospital, Changchun, Jilin, P.R. China, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, P.R. China, Department of Biological Sciences, University of Sargodha Sub-Campus Bhakkar, Punjab, Pakistan, Department of Pain Treatment, Binzhou Medical College Affiliated Hospital, Binzhou, Shandong, P.R. China
Published online on: July 30, 2014 https://doi.org/10.3892/or.2014.3368
Pages: 1585-1593

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human osteosarcoma is an aggressive tumor which frequently resists chemotherapy; therefore, the search for new agents for its treatment is of great importance. Isoalantolactone, isolated from Inula spp., has been reported to inhibit the growth of several types of cancer cells. However, no prior research has been conducted to demonstrate the antiproliferative potential of isoalantolactone on osteosarcoma. The present study is the first to investigate the effects of isoalantolactone on cell viability in human osteosarcoma U2OS, MG-63 and Saos-2 cells, and its mechanism of action in U2OS cells. Our results demonstrated that isoalantolactone triggered S and mainly G2/M cell cycle phase arrest, accompanied by the downregulation of the expression of cyclin B1 at the protein and mRNA levels. Moreover, isoalantolactone induced apoptosis that was associated with reactive oxygen species (ROS) generation and the dissipation of mitochondrial membrane potential (MMP). Furthermore, our results indicated that this compound upregulated DR5, FADD and cleaved caspase-8, increased the interation between DR5 and FADD, and inhibited the expression of nuclear NF-κBp65. We also found that isoalantolactone-induced apoptosis was associated with the downregulation of Bcl-2 and upregulation of Bax, which finally led to the activation of caspase-3 and its downstream substrate, PARP, in osteosarcoma U2OS cells. Isoalantolactone-induced apoptosis was markedly abrogated when the cells were pretreated with N-acetylcysteine (NAC), a specific ROS inhibitor, suggesting that the apoptosis-inducing effect of isoalantolactone in osteosarcoma cells was mediated by reactive oxygen species. Taken together, our data demonstrated that isoalantolactone induces ROS-dependent apoptosis in U2OS cells via a novel mechanism involving inhibition of NF-κBp65 and provide the rationale for further in vivo and preclinical investigation of isoalantolactone against osteosarcoma.

View Figures

View References

1	Broadhead ML, Clark JC, Myers DE, Dass CR and Choong PF: The molecular pathogenesis of osteosarcoma: a review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
2	Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
3	Marina N, Gebhardt M, Teot L and Gorlick R: Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
4	Kempf-Bielack B, Bielack SS, Jürgens H, et al: Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 23:559–568. 2005. View Article : Google Scholar : PubMed/NCBI
5	Wu M, Zhang H, Hu J, et al: Isoalantolactone inhibits UM-SCC-10A cell growth via cell cycle arrest and apoptosis induction. PLoS One. 8:e760002013. View Article : Google Scholar : PubMed/NCBI
6	Khan M, Ding C, Rasul A, et al: Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells. Int J Biol Sci. 8:533–547. 2012. View Article : Google Scholar : PubMed/NCBI
7	Konishi T, Shimada Y, Nagao T, Okabe H and Konoshima T: Antiproliferative sesquiterpene lactones from the roots of Inula helenium. Biol Pharm Bull. 25:1370–1372. 2002. View Article : Google Scholar : PubMed/NCBI
8	Rasul A, Khan M, Yu B, et al: Isoalantolactone, a sesquiterpene lactone, induces apoptosis in SGC-7901 cells via mitochondrial and phosphatidylinositol 3-kinase/Akt signaling pathways. Arch Pharm Res. 36:1262–1269. 2013. View Article : Google Scholar : PubMed/NCBI
9	Rasul A, Di J, Millimouno FM, et al: Reactive oxygen species mediate isoalantolactone-induced apoptosis in human prostate cancer cells. Molecules. 18:9382–9396. 2013. View Article : Google Scholar : PubMed/NCBI
10	Seo JY, Park J, Kim HJ, et al: Isoalantolactone from Inula helenium caused Nrf2-mediated induction of detoxifying enzymes. J Med Food. 12:1038–1045. 2009.
11	Fulda S and Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
12	Mühlethaler-Mottet A, Bourloud KB, Auderset K, Joseph JM and Gross N: Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-x_L and RIP. Oncogene. 23:5415–5425. 2004.
13	Kamachi M, Le TM, Kim SJ, Geiger ME, Anderson P and Utz PJ: Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway. J Exp Med. 196:1213–1225. 2002. View Article : Google Scholar : PubMed/NCBI
14	Tang D, Lahti JM and Kidd VJ: Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis. J Biol Chem. 275:9303–9307. 2000. View Article : Google Scholar : PubMed/NCBI
15	Khan M, Yi F, Rasul A, et al: Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction. IUBMB Life. 64:783–794. 2012. View Article : Google Scholar : PubMed/NCBI
16	Lu YJ, Yang SH, Chien CM, et al: Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDB, in chronic myeloid leukemia (HL-60) cells. Toxicol In Vitro. 21:90–98. 2007. View Article : Google Scholar : PubMed/NCBI
17	Torres K and Horwitz SB: Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res. 58:3620–3626. 1998.PubMed/NCBI
18	Gamet-Payrastre L, Li P, Lumeau S, et al: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 60:1426–1433. 2000.PubMed/NCBI
19	Murray AW: Recycling the cell cycle: cyclins revisited. Cell. 116:221–234. 2004. View Article : Google Scholar : PubMed/NCBI
20	Orren DK, Petersen LN and Bohr VA: Persistent DNA damage inhibits S-phase and G₂ progression, and results in apoptosis. Mol Biol Cell. 8:1129–1142. 1997. View Article : Google Scholar : PubMed/NCBI
21	Bodmer JL, Holler N, Reynard S, et al: TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol. 2:241–243. 2000. View Article : Google Scholar : PubMed/NCBI
22	Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA and Darwiche N: What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today. 15:668–678. 2010. View Article : Google Scholar : PubMed/NCBI
23	Lyss G, Knorre A, Schmidt TJ, Pahl HL and Merfort I: The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65. J Biol Chem. 273:33508–33516. 1998.
24	Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J and Hood L: Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity. 7:821–830. 1997.PubMed/NCBI
25	Juan ME, Wenzel U, Daniel H and Planas JM: Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. J Agric Food Chem. 56:4813–4818. 2008. View Article : Google Scholar : PubMed/NCBI
26	Schumacker PT: Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 10:175–176. 2006. View Article : Google Scholar : PubMed/NCBI
27	Gu JQ, Gills JJ, Park EJ, et al: Sesquiterpenoids from Tithonia diversifolia with potential cancer chemopreventive activity. J Nat Prod. 65:532–536. 2002.PubMed/NCBI
28	Koch E, Klaas CA, Rüngeler P, et al: Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-κB. Biochem Pharmacol. 62:795–801. 2001.PubMed/NCBI
29	Nam NH: Naturally occurring NF-κB inhibitors. Mini Rev Med Chem. 6:945–951. 2006.
30	Lee SM, Kwon JI, Choi YH, Eom HS and Chi GY: Induction of G2/M arrest and apoptosis by water extract of Strychni Semen in human gastric carcinoma AGS cells. Phytother Res. 22:752–758. 2008. View Article : Google Scholar : PubMed/NCBI
31	Rasul A, Yu B, Zhong L, Khan M, Yang H and Ma T: Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy. Oncol Rep. 27:1481–1487. 2012.PubMed/NCBI
32	Scott FL, Stec B, Pop C, et al: The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature. 457:1019–1022. 2009. View Article : Google Scholar : PubMed/NCBI
33	Guicciardi ME and Gores GJ: Life and death by death receptors. FASEB J. 23:1625–1637. 2009. View Article : Google Scholar : PubMed/NCBI
34	Gaeta ML, Johnson DR, Kluger MS and Pober JS: The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization. Lab Invest. 80:1185–1194. 2000. View Article : Google Scholar
35	Sheikh MS and Fornace AJ Jr: Death and decoy receptors and p53-mediated apoptosis. Leukemia. 14:1509–1513. 2000. View Article : Google Scholar : PubMed/NCBI
36	Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP and Prabhakar BS: IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC. Oncogene. 23:6083–6094. 2004. View Article : Google Scholar : PubMed/NCBI
37	MacEwan DJ: TNF ligands and receptors - a matter of life and death. Br J Pharmacol. 135:855–875. 2002. View Article : Google Scholar : PubMed/NCBI
38	Stanger BZ, Leder P, Lee TH, Kim E and Seed B: RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 81:513–523. 1995. View Article : Google Scholar : PubMed/NCBI
39	Hsu H, Shu HB, Pan MG and Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:299–308. 1996. View Article : Google Scholar : PubMed/NCBI
40	Bharti AC, Donato N, Singh S and Aggarwal BB: Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 101:1053–1062. 2003.PubMed/NCBI
41	Li Q, Yu YY, Zhu ZG, et al: Effect of NF-κB constitutive activation on proliferation and apoptosis of gastric cancer cell lines. European surgical research. Eur Surg Res. 37:105–110. 2005.
42	Shen HM and Tergaonkar V: NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis. 14:348–363. 2009.
43	Jeong SY and Seol DW: The role of mitochondria in apoptosis. BMB Rep. 41:11–22. 2008. View Article : Google Scholar
44	Danial NN: BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res. 13:7254–7263. 2007. View Article : Google Scholar : PubMed/NCBI
45	Frenzel A, Grespi F, Chmelewskij W and Villunger A: Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis. 14:584–596. 2009. View Article : Google Scholar : PubMed/NCBI
46	Wei W, Huang H, Zhao S, et al: Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion. Apoptosis. 18:1060–1070. 2013.
47	Felty Q, Xiong WC, Sun D, et al: Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry. 44:6900–6909. 2005. View Article : Google Scholar : PubMed/NCBI
48	Jabs T: Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol. 57:231–245. 1999. View Article : Google Scholar : PubMed/NCBI